Global Erythropoietin Market Outlook 2023

Report ID: 1237589 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Erythropoietin Market Overview
    1.1 Product Overview and Scope of Erythropoietin
    1.2 Erythropoietin Segment by Type
        1.2.1 Global Erythropoietin Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Epoetin-alfa
        1.2.3 Epoetin-beta
        1.2.4 Darbepoetin-alfa
        1.2.5 Others
    1.3 Erythropoietin Segment by Application
        1.3.1 Global Erythropoietin Sales Comparison by Application: (2021-2027)
        1.3.2 Anemia
        1.3.3 Kidney Disorders
        1.3.4 Others
    1.4 Global Erythropoietin Market Size Estimates and Forecasts
        1.4.1 Global Erythropoietin Revenue 2016-2027
        1.4.2 Global Erythropoietin Sales 2016-2027
        1.4.3 Erythropoietin Market Size by Region: 2016 Versus 2021 Versus 2027

2 Erythropoietin Market Competition by Manufacturers
    2.1 Global Erythropoietin Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Erythropoietin Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Erythropoietin Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Erythropoietin Manufacturing Sites, Area Served, Product Type
    2.5 Erythropoietin Market Competitive Situation and Trends
        2.5.1 Erythropoietin Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Erythropoietin Players Market Share by Revenue
        2.5.3 Global Erythropoietin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Erythropoietin Retrospective Market Scenario by Region
    3.1 Global Erythropoietin Retrospective Market Scenario in Sales by Region: 2016-2021
    3.2 Global Erythropoietin Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.3 North America Erythropoietin Market Facts & Figures by Country
        3.3.1 North America Erythropoietin Sales by Country
        3.3.2 North America Erythropoietin Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Erythropoietin Market Facts & Figures by Country
        3.4.1 Europe Erythropoietin Sales by Country
        3.4.2 Europe Erythropoietin Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Erythropoietin Market Facts & Figures by Region
        3.5.1 Asia Pacific Erythropoietin Sales by Region
        3.5.2 Asia Pacific Erythropoietin Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Erythropoietin Market Facts & Figures by Country
        3.6.1 Latin America Erythropoietin Sales by Country
        3.6.2 Latin America Erythropoietin Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Erythropoietin Market Facts & Figures by Country
        3.7.1 Middle East and Africa Erythropoietin Sales by Country
        3.7.2 Middle East and Africa Erythropoietin Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Erythropoietin Historic Market Analysis by Type
    4.1 Global Erythropoietin Sales Market Share by Type (2016-2021)
    4.2 Global Erythropoietin Revenue Market Share by Type (2016-2021)
    4.3 Global Erythropoietin Price by Type (2016-2021)

5 Global Erythropoietin Historic Market Analysis by Application
    5.1 Global Erythropoietin Sales Market Share by Application (2016-2021)
    5.2 Global Erythropoietin Revenue Market Share by Application (2016-2021)
    5.3 Global Erythropoietin Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Amgen
        6.1.1 Amgen Corporation Information
        6.1.2 Amgen Description and Business Overview
        6.1.3 Amgen Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Amgen Erythropoietin Product Portfolio
        6.1.5 Amgen Recent Developments/Updates
    6.2 Johnson & Johnson
        6.2.1 Johnson & Johnson Corporation Information
        6.2.2 Johnson & Johnson Description and Business Overview
        6.2.3 Johnson & Johnson Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Johnson & Johnson Erythropoietin Product Portfolio
        6.2.5 Johnson & Johnson Recent Developments/Updates
    6.3 Roche
        6.3.1 Roche Corporation Information
        6.3.2 Roche Description and Business Overview
        6.3.3 Roche Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Roche Erythropoietin Product Portfolio
        6.3.5 Roche Recent Developments/Updates
    6.4 Galenica
        6.4.1 Galenica Corporation Information
        6.4.2 Galenica Description and Business Overview
        6.4.3 Galenica Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Galenica Erythropoietin Product Portfolio
        6.4.5 Galenica Recent Developments/Updates
    6.5 Emcure
        6.5.1 Emcure Corporation Information
        6.5.2 Emcure Description and Business Overview
        6.5.3 Emcure Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Emcure Erythropoietin Product Portfolio
        6.5.5 Emcure Recent Developments/Updates
    6.6 Kyowa Hakko Kirin
        6.6.1 Kyowa Hakko Kirin Corporation Information
        6.6.2 Kyowa Hakko Kirin Description and Business Overview
        6.6.3 Kyowa Hakko Kirin Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Kyowa Hakko Kirin Erythropoietin Product Portfolio
        6.6.5 Kyowa Hakko Kirin Recent Developments/Updates
    6.7 3SBio
        6.6.1 3SBio Corporation Information
        6.6.2 3SBio Description and Business Overview
        6.6.3 3SBio Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 3SBio Erythropoietin Product Portfolio
        6.7.5 3SBio Recent Developments/Updates
    6.8 Biocon
        6.8.1 Biocon Corporation Information
        6.8.2 Biocon Description and Business Overview
        6.8.3 Biocon Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Biocon Erythropoietin Product Portfolio
        6.8.5 Biocon Recent Developments/Updates
    6.9 LG Life Sciences
        6.9.1 LG Life Sciences Corporation Information
        6.9.2 LG Life Sciences Description and Business Overview
        6.9.3 LG Life Sciences Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 LG Life Sciences Erythropoietin Product Portfolio
        6.9.5 LG Life Sciences Recent Developments/Updates

7 Erythropoietin Manufacturing Cost Analysis
    7.1 Erythropoietin Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Erythropoietin
    7.4 Erythropoietin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Erythropoietin Distributors List
    8.3 Erythropoietin Customers

9 Erythropoietin Market Dynamics
    9.1 Erythropoietin Industry Trends
    9.2 Erythropoietin Growth Drivers
    9.3 Erythropoietin Market Challenges
    9.4 Erythropoietin Market Restraints

10 Global Market Forecast
    10.1 Erythropoietin Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Erythropoietin by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Erythropoietin by Type (2022-2027)
    10.2 Erythropoietin Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Erythropoietin by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Erythropoietin by Application (2022-2027)
    10.3 Erythropoietin Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Erythropoietin by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Erythropoietin by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
List of Tables
    Table 1. Global Erythropoietin Sales (M Units) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Erythropoietin Sales (M Units) Comparison by Application (2021-2027)
    Table 3. Global Erythropoietin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Erythropoietin Covered in This Study
    Table 5. Global Erythropoietin Sales (M Units) of Key Manufacturers (2016-2021)
    Table 6. Global Erythropoietin Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Erythropoietin Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Erythropoietin Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Erythropoietin Average Price (US$/Unit) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Erythropoietin Manufacturing Sites and Area Served
    Table 11. Manufacturers Erythropoietin Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Erythropoietin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erythropoietin as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Erythropoietin Sales by Region (2016-2021) & (M Units)
    Table 16. Global Erythropoietin Sales Market Share by Region (2016-2021)
    Table 17. Global Erythropoietin Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Erythropoietin Sales by Country (2016-2021) & (M Units)
    Table 19. North America Erythropoietin Sales Market Share by Country (2016-2021)
    Table 20. North America Erythropoietin Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Erythropoietin Revenue Market Share by Country (2016-2021)
    Table 22. Europe Erythropoietin Sales by Country (2016-2021) & (M Units)
    Table 23. Europe Erythropoietin Sales Market Share by Country (2016-2021)
    Table 24. Europe Erythropoietin Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Erythropoietin Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Erythropoietin Sales by Region (2016-2021) & (M Units)
    Table 27. Asia Pacific Erythropoietin Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Erythropoietin Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Erythropoietin Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Erythropoietin Sales by Country (2016-2021) & (M Units)
    Table 31. Latin America Erythropoietin Sales Market Share by Country (2016-2021)
    Table 32. Latin America Erythropoietin Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Erythropoietin Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Erythropoietin Sales by Country (2016-2021) & (M Units)
    Table 35. Middle East and Africa Erythropoietin Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Erythropoietin Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Erythropoietin Revenue Market Share by Country (2016-2021)
    Table 38. Global Erythropoietin Sales (M Units) by Type (2016-2021)
    Table 39. Global Erythropoietin Sales Market Share by Type (2016-2021)
    Table 40. Global Erythropoietin Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Erythropoietin Revenue Share by Type (2016-2021)
    Table 42. Global Erythropoietin Price (US$/Unit) by Type (2016-2021)
    Table 43. Global Erythropoietin Sales (M Units) by Application (2016-2021)
    Table 44. Global Erythropoietin Sales Market Share by Application (2016-2021)
    Table 45. Global Erythropoietin Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Erythropoietin Revenue Share by Application (2016-2021)
    Table 47. Global Erythropoietin Price (US$/Unit) by Application (2016-2021)
    Table 48. Amgen Corporation Information
    Table 49. Amgen Description and Business Overview
    Table 50. Amgen Erythropoietin Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 51. Amgen Erythropoietin Product
    Table 52. Amgen Recent Developments/Updates
    Table 53. Johnson & Johnson Corporation Information
    Table 54. Johnson & Johnson Description and Business Overview
    Table 55. Johnson & Johnson Erythropoietin Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 56. Johnson & Johnson Erythropoietin Product
    Table 57. Johnson & Johnson Recent Developments/Updates
    Table 58. Roche Corporation Information
    Table 59. Roche Description and Business Overview
    Table 60. Roche Erythropoietin Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 61. Roche Erythropoietin Product
    Table 62. Roche Recent Developments/Updates
    Table 63. Galenica Corporation Information
    Table 64. Galenica Description and Business Overview
    Table 65. Galenica Erythropoietin Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 66. Galenica Erythropoietin Product
    Table 67. Galenica Recent Developments/Updates
    Table 68. Emcure Corporation Information
    Table 69. Emcure Description and Business Overview
    Table 70. Emcure Erythropoietin Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 71. Emcure Erythropoietin Product
    Table 72. Emcure Recent Developments/Updates
    Table 73. Kyowa Hakko Kirin Corporation Information
    Table 74. Kyowa Hakko Kirin Description and Business Overview
    Table 75. Kyowa Hakko Kirin Erythropoietin Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 76. Kyowa Hakko Kirin Erythropoietin Product
    Table 77. Kyowa Hakko Kirin Recent Developments/Updates
    Table 78. 3SBio Corporation Information
    Table 79. 3SBio Description and Business Overview
    Table 80. 3SBio Erythropoietin Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 81. 3SBio Erythropoietin Product
    Table 82. 3SBio Recent Developments/Updates
    Table 83. Biocon Corporation Information
    Table 84. Biocon Description and Business Overview
    Table 85. Biocon Erythropoietin Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 86. Biocon Erythropoietin Product
    Table 87. Biocon Recent Developments/Updates
    Table 88. LG Life Sciences Corporation Information
    Table 89. LG Life Sciences Description and Business Overview
    Table 90. LG Life Sciences Erythropoietin Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 91. LG Life Sciences Erythropoietin Product
    Table 92. LG Life Sciences Recent Developments/Updates
    Table 93. Production Base and Market Concentration Rate of Raw Material
    Table 94. Key Suppliers of Raw Materials
    Table 95. Erythropoietin Distributors List
    Table 96. Erythropoietin Customers List
    Table 97. Erythropoietin Market Trends
    Table 98. Erythropoietin Growth Drivers
    Table 99. Erythropoietin Market Challenges
    Table 100. Erythropoietin Market Restraints
    Table 101. Global Erythropoietin Sales Forecast by Type (2022-2027) & (M Units)
    Table 102. Global Erythropoietin Sales Market Share Forecast by Type (2022-2027)
    Table 103. Global Erythropoietin Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 104. Global Erythropoietin Revenue Market Share Forecast by Type (2022-2027)
    Table 105. Global Erythropoietin Sales Forecast by Application (2022-2027) & (M Units)
    Table 106. Global Erythropoietin Sales Market Share Forecast by Application (2022-2027)
    Table 107. Global Erythropoietin Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 108. Global Erythropoietin Revenue Market Share Forecast by Application (2022-2027)
    Table 109. Global Erythropoietin Sales Forecast by Region (2022-2027) & (M Units)
    Table 110. Global Erythropoietin Sales Market Share Forecast by Region (2022-2027)
    Table 111. Global Erythropoietin Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 112. Global Erythropoietin Revenue Market Share Forecast by Region (2022-2027)
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Erythropoietin
    Figure 2. Global Erythropoietin Market Share by Type in 2020 & 2027
    Figure 3. Epoetin-alfa Product Picture
    Figure 4. Epoetin-beta Product Picture
    Figure 5. Darbepoetin-alfa Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Erythropoietin Market Share by Application in 2020 & 2027
    Figure 8. Anemia
    Figure 9. Kidney Disorders
    Figure 10. Others
    Figure 11. Global Erythropoietin Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Erythropoietin Market Size 2016-2027 (US$ Million)
    Figure 13. Global Erythropoietin Sales 2016-2027 (M Units)
    Figure 14. Global Erythropoietin Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 15. Erythropoietin Sales Share by Manufacturers in 2020
    Figure 16. Global Erythropoietin Revenue Share by Manufacturers in 2020
    Figure 17. The Global 5 and 10 Largest Erythropoietin Players: Market Share by Revenue in 2020
    Figure 18. Erythropoietin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 19. Global Erythropoietin Sales Market Share by Region (2016-2021)
    Figure 20. Global Erythropoietin Sales Market Share by Region in 2020
    Figure 21. Global Erythropoietin Revenue Market Share by Region (2016-2021)
    Figure 22. Global Erythropoietin Revenue Market Share by Region in 2020
    Figure 23. U.S. Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. Canada Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. Germany Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. France Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. U.K. Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Italy Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. Russia Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. China Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. Japan Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. South Korea Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. India Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Australia Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. China Taiwan Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Indonesia Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Thailand Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Malaysia Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Mexico Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Brazil Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Argentina Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Turkey Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Saudi Arabia Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. UAE Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Sales Market Share of Erythropoietin by Type (2016-2021)
    Figure 46. Sales Market Share of Erythropoietin by Application (2016-2021)
    Figure 47. Sales Market Share of Erythropoietin by Application in 2020
    Figure 48. Revenue Share of Erythropoietin by Application (2016-2021)
    Figure 49. Revenue Share of Erythropoietin by Application in 2020
    Figure 50. Manufacturing Cost Structure of Erythropoietin
    Figure 51. Manufacturing Process Analysis of Erythropoietin
    Figure 52. Erythropoietin Industrial Chain Analysis
    Figure 53. Channels of Distribution
    Figure 54. Distributors Profiles
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Frequently Asked Questions
Erythropoietin report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Erythropoietin report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Erythropoietin report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

V-belts

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More